Evidence map›Paper›PMID 25739669›Full record

ArticleMycopathologia2015

Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and Risk Factors.

Sezin Zorlu Sahin, Halis Akalin, Alparslan Ersoy, Abdulmecit Yildiz, Gökhan Ocakoglu, Ezgi Demirdöven Cetinoglu, Oğuzhan Sıtkı Dizdar, Esra Kazak, Beyza Ener

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. De novo belatacept-based immunosuppression is not associated with increased risk of invasive fungal infection in kidney transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  3. Article
  4. Article
  5. Risk factors for development and mortality of invasive pulmonary Aspergillosis in kidney transplantation recipients.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sezin Zorlu SahinDepartment of Microbiology and Infectious Diseases, Uludag University Medical School, 16059, Gorukle, Nilufer, Bursa, Turkey, sezinz@hotmail.com.
Halis Akalin
Alparslan Ersoy
Abdulmecit Yildiz
Gökhan Ocakoglu
Ezgi Demirdöven Cetinoglu
Oğuzhan Sıtkı Dizdar
Esra Kazak
Beyza Ener
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInvasive fungal infections are a major cause of morbidity and mortality among renal transplant recipients.

objectivesThe aim of this study was to investigate the frequency and risk factors for fungal infections in renal transplant recipients.

methodsWe retrospectively evaluated all kidney transplant recipients at our center from December 1988 to June 2010 for the epidemiology, spectrum, risk factors, and mortality of invasive fungal infections.

resultsIn 32 patients (10.30 %), at least one fungal infection developed after the transplantation. The most common pathogens causing fungal infections in our patients were Candida spp. and Aspergillus spp. The independent risk factors associated with invasive fungal infection episodes were antibiotic treatment within the last 3 months (OR 15.88, 95 % CI 3.90-64.73, p < 0.001), cytomegalovirus infection (OR 18.54, 95 % CI 9.01-38.17, p < 0.001), and the presence of diabetes mellitus (OR 6.01, 95 % CI 2.95-12.25, p < 0.001). Mortality was significantly higher among patients with fungal infections than among other patients (53.10 and 17.80 %, respectively; p < 0.001).

conclusionsIt is difficult to diagnose and treat fungal infections early, and it can be useful to determine independent risk factors in order to identify and treat high-risk patients.

Indexed as

Kidney TransplantationTransplant RecipientsAdolescentAdultAgedAnti-Bacterial AgentsCytomegalovirus InfectionsDiabetes ComplicationsFemaleFungemiaFungiHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAnti-Bacterial Agents

Identifiers

PMID25739669
OpenAlexW1968386012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.